Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis?
作者信息
Soldin Offie Porat, Elin Ronald J, Soldin Steven J
机构信息
Consultants in Epidemiology and Occupational Health, Washington, DC, USA.
出版信息
Arch Pathol Lab Med. 2003 Jan;127(1):102-5. doi: 10.5858/2003-127-102-TDMIHI.
Abstract
摘要
相似文献
1
Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis?人类免疫缺陷病毒/获得性免疫缺陷综合征中的治疗药物监测。何去何从？
Arch Pathol Lab Med. 2003 Jan;127(1):102-5. doi: 10.5858/2003-127-102-TDMIHI.
2
[AIDS triple therapy. The gap between viral load and side effects].[艾滋病三联疗法。病毒载量与副作用之间的差距]
Fortschr Med. 1998 Sep 30;116(27):4-5.
3
Improvement in CD4+ cell counts despite persistently detectable HIV load.尽管HIV载量持续可检测到，但CD4+细胞计数仍有所改善。
N Engl J Med. 1998 Apr 9;338(15):1074-5. doi: 10.1056/NEJM199804093381517.
4
[Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].[1994年与2004年的抗逆转录病毒疗法。典型病例所呈现的现实情况]
MMW Fortschr Med. 2004 Apr 26;146 Spec No 1:72-3.
5
[Antiviral therapy: when to begin, which goals should be set, what must be kept in mind? Tips for nonspecialists].
MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:10-1.
6
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.人类免疫缺陷病毒（HIV）感染个体血清的中和谱：与HIV病毒载量及CD4细胞计数的关系。
Clin Diagn Lab Immunol. 2000 May;7(3):412-6. doi: 10.1128/CDLI.7.3.412-416.2000.
7
Starting, stopping, picking, and switching antiretrovirals or, the ring in the river. Glasgow: Part 2.
IAPAC Mon. 2001 Feb;7(2):54-66.
8
AIDS freak-time to give up?艾滋病患者——是时候放弃了吗？
Hopkins HIV Rep. 2001 Nov;13(6):11.
9
Therapies. Confronting the limits of success.疗法。直面成功的局限。
Science. 2002 Jun 28;296(5577):2320-4. doi: 10.1126/science.296.5577.2320.
10
Antiretroviral therapy for human immunodeficiency virus disease: implications for critical care nursing.人类免疫缺陷病毒病的抗逆转录病毒治疗：对重症护理的影响。
Crit Care Nurse. 1998 Dec;18(6):54-62.
引用本文的文献
1
The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury.皮质酮在奈韦拉平所致药物性肝损伤中的作用。
Toxicol Sci. 2024 Jun 26;200(1):146-164. doi: 10.1093/toxsci/kfae054.
2
The Structure-To-Function Relationships of Gammaherpesvirus-Encoded Long Non-Coding RNAs and Their Contributions to Viral Pathogenesis.γ疱疹病毒编码的长链非编码RNA的结构与功能关系及其对病毒致病机制的作用
Noncoding RNA. 2018 Sep 26;4(4):24. doi: 10.3390/ncrna4040024.
3
Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients.细胞色素P450 2B6基因型对人类免疫缺陷病毒患者中依非韦伦群体药代动力学的影响。
Antimicrob Agents Chemother. 2009 Jul;53(7):2791-8. doi: 10.1128/AAC.01537-08. Epub 2009 May 11.
4
Application and impact of population pharmacokinetics in the assessment of antiretroviral pharmacotherapy.群体药代动力学在抗逆转录病毒药物治疗评估中的应用及影响
Clin Pharmacokinet. 2005;44(6):591-625. doi: 10.2165/00003088-200544060-00003.
本文引用的文献
1
The economics of HIV in Africa.
Lancet. 2002 Jul 6;360(9326):1.
2
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.高效液相色谱法同时测定人血浆中六种HIV蛋白酶抑制剂和两种非核苷类逆转录酶抑制剂
Ther Drug Monit. 2002 Jun;24(3):417-24. doi: 10.1097/00007691-200206000-00015.
3
Critical issues in therapeutic drug monitoring of antiretroviral drugs.抗逆转录病毒药物治疗药物监测中的关键问题。
Ther Drug Monit. 2002 Jun;24(3):323-31. doi: 10.1097/00007691-200206000-00001.
4
Simple rapid method for quantification of antiretrovirals by liquid chromatography-tandem mass-spectrometry.通过液相色谱-串联质谱法定量抗逆转录病毒药物的简单快速方法。
Clin Biochem. 2002 Mar;35(2):99-103. doi: 10.1016/s0009-9120(02)00286-2.
5
Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.与传统抗逆转录病毒疗法相比，用于治疗HIV感染的浓度控制疗法。
AIDS. 2002 Mar 8;16(4):551-60. doi: 10.1097/00002030-200203080-00006.
6
Review: therapeutic drug monitoring in pediatrics.综述：儿科治疗药物监测
Ther Drug Monit. 2002 Feb;24(1):1-8. doi: 10.1097/00007691-200202000-00001.
7
Pharmacokinetic and other drug interactions in patients with AIDS.艾滋病患者的药代动力学及其他药物相互作用。
Ther Drug Monit. 2001 Dec;23(6):591-605. doi: 10.1097/00007691-200112000-00001.
8
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.抗逆转录病毒药物：通过快速高效液相色谱 - 质谱分析法同时测定人血浆中的五种蛋白酶抑制剂和三种非核苷转录酶抑制剂。
Ther Drug Monit. 2001 Aug;23(4):380-8. doi: 10.1097/00007691-200108000-00010.
9
Clinical Pharmacologic Considerations for HIV-1 Protease Inhibitors.
Curr Infect Dis Rep. 2001 Aug;3(4):381-387. doi: 10.1007/s11908-001-0079-3.
10
Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry.液相色谱-串联质谱法同时简单快速定量三种主要免疫抑制剂
Clin Biochem. 2001 Jun;34(4):285-90. doi: 10.1016/s0009-9120(01)00235-1.
Zotero 插件